OMX Nordic 40
2.347,19
PKT
-25,69
PKT
-1,08
%
Werbung
Analysen zu OMX Nordic 40-Werten
Datum | Rating | Analyst | |
---|---|---|---|
20.10.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
19.10.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
19.10.22 | Volvo (B) Sector Perform | RBC Capital Markets | |
18.10.22 | AstraZeneca Buy | Deutsche Bank AG | |
18.10.22 | Nokia Overweight | JP Morgan Chase & Co. | |
14.10.22 | Novo Nordisk Buy | Deutsche Bank AG | |
14.10.22 | Novo Nordisk Overweight | Barclays Capital | |
13.10.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
13.10.22 | Volvo (B) Sell | UBS AG | |
13.10.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
13.10.22 | Nokia Equal Weight | Barclays Capital | |
12.10.22 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
12.10.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
12.10.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
11.10.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
10.10.22 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
07.10.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
07.10.22 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
07.10.22 | Novo Nordisk Buy | Deutsche Bank AG | |
07.10.22 | AstraZeneca Buy | Deutsche Bank AG | |
07.10.22 | Nokia Buy | UBS AG | |
05.10.22 | AstraZeneca Neutral | Credit Suisse Group | |
04.10.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.10.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
04.10.22 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
03.10.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.10.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
03.10.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
03.10.22 | Novo Nordisk Overweight | Barclays Capital | |
03.10.22 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
03.10.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
30.09.22 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
30.09.22 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
30.09.22 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
29.09.22 | Hennes Mauritz (H M, H&M) Underperform | Credit Suisse Group | |
29.09.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
29.09.22 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
29.09.22 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
29.09.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
29.09.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets |